RTX (RTX) Q3 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 23/24 earnings summary
27 Jul, 2026Executive summary
Q3 revenue reached DKK 142 million, showing sequential growth and exceeding expectations due to late-quarter shipments, but still below year-over-year levels and earlier guidance, with order intake and visibility remaining limited.
Gross margin improved to 48% in Q3, up from earlier quarters, driven by product mix, supply chain normalization, and higher revenue.
EBITDA for Q3 was DKK 9 million, turning positive and reflecting cost control, but still below target and down from DKK 14 million year-over-year.
Management revised full-year outlook downward in June due to postponed orders and lower demand, especially in ProAudio and Enterprise segments.
Financial highlights
Q3 revenue: DKK 142 million; 9M revenue: DKK 349 million, down 37% year-over-year.
Q3 EBITDA: DKK 9 million; 9M EBITDA: DKK -20 million, impacted by lower revenue but improving sequentially.
Q3 gross margin: 48%; 9M gross margin: 45%.
Inventory reduced by DKK 9 million in Q3 and DKK 11 million over nine months, with no obsolete inventory risks.
Cash and cash equivalents at Q3: DKK 100 million, up from DKK 91 million year-over-year.
Outlook and guidance
Full-year 2023/24 revenue expected at DKK 500–510 million (previously DKK 580–630 million); EBITDA at DKK 0–10 million (previously DKK 45–60 million); EBIT at DKK -40 to -30 million (previously DKK 5–20 million).
No new guidance for next year until the annual report; visibility remains low with customer forecasts limited to 3–6 months.
Normalization of customer inventory and demand expected over the next 12 months, but timing remains uncertain.
Majority of revenue to come from existing products; up to 20% from new launches.
Gross margin expected to improve sequentially but remain below last year due to lower revenue.
Latest events from RTX
- H1 revenue and EBITDA rose, gross margin improved, and full-year guidance is maintained.RTX
Q2 25/26 - H1 revenue and EBITDA rose, driven by Healthcare and ProAudio; guidance remains despite supply risks.RTX
Q2 25/26 - Revenue up 7% year-over-year, gross margin and liquidity improved, guidance maintained.RTX
Q1 25/26 - Revenue up 7% to DKK 108m, with strong Healthcare and ProAudio growth, margin up to 54.9%.RTX
Q1 25/26 - Revenue up 10%, gross margin at 50%-51%, EBITDA surged, and outlook remains positive.RTX
Q4 24/25 - Double-digit revenue growth and margin expansion achieved, with strong outlook for 2025/26.RTX
Q4 24/25 - Strong revenue and margin growth led to raised guidance and a DKK 20m share buyback.RTX
Q3 24/25 - Revenue and EBITDA fell, but gross margin rose; outlook remains cautious amid supply chain issues.RTX
Q4 23/24 - Revenue up 23% and gross margin at 51%, led by Enterprise; outlook limited by short order horizons.RTX
Q1 24/25